INS and diabetes mellitus: Currently, the common first-line pharmacological treatment for diabetes in many settings, including low-income ones where detailed metabolic investigations are often not possible, is metformin which acts primarily on insulin resistance; however, it may not be the best treatment in populations where low insulin production is a major concern(90).